Covered recipient · General Payments record
JACOB C RUBE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$5,244.48
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,396.67 | 3 |
| Food and Beverage | $245.74 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Scientific Affairs, LLC | $887.50 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $309.17 | 1 |
| UCB, Inc. | $227.29 | 5 |
| ABBVIE INC. | $104.32 | 4 |
| TG THERAPEUTICS, INC. | $37.93 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $36.84 | 2 |
| Genentech USA, Inc. | $20.33 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.13 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983705 | CMS |
| ABBVIE INC. | $23.48 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983707 | CMS |
| ABBVIE INC. | $33.10 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983709 | CMS |
| ABBVIE INC. | $27.61 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105983711 | CMS |
| Genentech USA, Inc. | $20.33 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133023542 | CMS |
| Janssen Scientific Affairs, LLC | $887.50 | 10/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1078852354 | CMS |
| Novartis Pharmaceuticals Corporation | $17.25 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087217633 | CMS |
| Novartis Pharmaceuticals Corporation | $19.59 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087217635 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.03 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137665278 | CMS |
| TG Therapeutics, Inc. | $20.06 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136870298 | CMS |
| TG Therapeutics, Inc. | $17.87 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136870344 | CMS |
| UCB, Inc. | $1.48 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143394159 | CMS |
| UCB, Inc. | $10.12 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143394163 | CMS |
| UCB, Inc. | $200.00 | 03/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1143394168 | CMS |
| UCB, Inc. | $1.84 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143394172 | CMS |
| UCB, Inc. | $13.85 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143394176 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $309.17 | 09/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105922841 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.